Daito Pharmaceutical Co.,Ltd.
Notice of Change of Representative Director, Appointment of New Director Candidates, and Change of Executive Officers
Announcement of the appointment of three new director candidates and changes to directors and executive officers. Resignation of the representative director with a view to becoming chairman, new appointments and transfers of executive officers, and the establishment of a new department due to organizational restructuring.
Key Figures
- Three new director candidates
- Organizational restructuring: Establishment of Business Development Headquarters and Human Resources and General Affairs Headquarters
- Change of representative director (becoming Chairman, planned resignation date August 27, 2026)
AI要約
Section Heading
At today’s board of directors meeting, we resolved the appointment of a non-audit committee director candidate and the change of the representative director. The new director candidates are Toyo Kuwashima (Executive Managing Officer, Head of Assurance and Reliability), Takeshi Otsuka (Executive Officer, CFO), and Hiroko Kusano (new; external).
Section 2 Heading
As for executive officers, Nobuhiro Yagi and five others will be newly appointed or transferred, and due to organizational restructuring, the Business Development Headquarters and the Human Resources and General Affairs Headquarters will be newly established. The expected resignations of executive officers are also noted, effective as of August 27.
Daito Co., Ltd.
Company overview · Stock price · Financial data · All IR
